<DOC>
	<DOCNO>NCT00488007</DOCNO>
	<brief_summary>This 12-months ' randomized clinical trial aim study benefit bilateral hearing aid hearing impaired patient suffer slight moderate stage Alzheimer disease . The benefit intervention study cognitive , behavioural , quality life economic field . 2groups involved trial : Intervention group : 12 month ' treatment active hearing aid , fit hearing impairment Control group : 6 month ' treatment placebo hearing aid , follow 6 month ' active hearing aid , fit hearing impairment</brief_summary>
	<brief_title>Clinical Trial Alzheimer Disease , Presbycusis Hearing Aids</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Presbycusis</mesh_term>
	<criteria>&gt; 65 yearold Medical diagnosis Alzheimer disease 15 ≤ MMSE ≤ 25 No hearing aid last 2 year Motivated caregiver live patient Sensorineural hearing loss Beginning anticholinesterasic treatment last 6 month Change anticholinesterasic treatment last 2 month</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Alzheimer disease</keyword>
	<keyword>Cognitive impairment</keyword>
	<keyword>Sensorineural hearing loss</keyword>
	<keyword>Hearing aid</keyword>
</DOC>